Percutaneous microwave ablation with artificial ascites for symptomatic uterine adenomyosis: initial experience

Abstract Purpose: To evaluate the feasibility, safety and technical efficacy of ultrasound-guided percutaneous microwave ablation with artificial ascites for adenomyosis. Materials and methods: Between May 2015 and May 2016, a total of 25 patients with symptomatic adenomyosis who underwent ultrasound-guided percutaneous microwave ablation with artificial ascites were included in this retrospective study. A matching cohort of 50 patients underwent ultrasound-guided percutaneous microwave ablation without artificial ascites as controls. The technical efficacy, complications and short-term treatment effectiveness were assessed and compared with the controls. Results: Artificial ascites was successfully achieved in all of the 25 patients with the administration of a median of 550 mL (range, 250–1200 mL) of solution. There was substantial improvement in achieving a better antenna path in 100% (20/20) of the cases with a poor antenna path. The complete separation was achieved in 23 of 25 patients. The mean ablation time was 26.5 ± 7.3 min and the median non-perfusion volume ratio was 76% which was similar to the control group (p > .05). No serious complications were observed. Patient pain scores for dysmenorrhoea showed a statistically significant decline from the baseline of 6.71 ± 0.96 to 2.92 ± 0.79 and the symptom severity score declined statistically significantly from 21.8 ± 5.5 to 16.4 ± 4.8 at 3 months follow-up. Conclusions: Percutaneous microwave ablation with artificial ascites is feasible, safe and can be effective in improving access for treatment of adenomyosis.

[1]  M. Beland,et al.  Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients , 2016, European Radiology.

[2]  Zhi-yu Han,et al.  Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis , 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[3]  Lian Zhang,et al.  Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: A retrospective study , 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[4]  M. Bedaiwy,et al.  Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. , 2016, Journal of minimally invasive gynecology.

[5]  F. Orsi,et al.  Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[6]  Zhibiao Wang,et al.  Efficacy of high-intensity focused ultrasound ablation for adenomyosis therapy and sexual life quality. , 2015, International journal of clinical and experimental medicine.

[7]  Zhang Jing,et al.  Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function , 2015, Scientific Reports.

[8]  P. Liang,et al.  A retrospective comparison of microwave ablation and high intensity focused ultrasound for treating symptomatic uterine fibroids. , 2015, European journal of radiology.

[9]  C. Huh,et al.  Rectouterine fistula after laparoscopic ultrasound-guided radiofrequency ablation of a uterine fibroid , 2014, Obstetrics & gynecology science.

[10]  Zhang Jing,et al.  Research of dose-effect relationship parameters of percutaneous microwave ablation for uterine leiomyomas - a quantitative study , 2014, Scientific Reports.

[11]  P. Liang,et al.  Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract , 2014, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[12]  E. Baracat,et al.  Patients with adenomyosis are more likely to have deep endometriosis , 2012, Gynecological Surgery.

[13]  Wen-Zhi Chen,et al.  Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. , 2011, Fertility and sterility.

[14]  H. Homer,et al.  Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. , 2010, Fertility and sterility.

[15]  H. Rhim,et al.  Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients , 2009, European Radiology.

[16]  Ping Liang,et al.  Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients. , 2009, Radiology.

[17]  D. Lu,et al.  The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. , 2009, Contraception.

[18]  H. Rhim,et al.  Does Artificial Ascites Induce the Heat-Sink Phenomenon during Percutaneous Radiofrequency Ablation of the Hepatic Subcapsular Area?: an in vivo Experimental Study Using a Rabbit Model , 2009, Korean journal of radiology.

[19]  Z. Holub,et al.  Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. , 2008, Fertility and sterility.

[20]  Y. Na,et al.  Successful use of magnetic resonance-guided focused ultrasound surgery to relieve symptoms in a patient with symptomatic focal adenomyosis. , 2008, Fertility and sterility.

[21]  L. Bahamondes,et al.  Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. , 2007, Contraception.

[22]  Y. Hiasa,et al.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites , 2007, Journal of Gastroenterology.

[23]  B. Hamm,et al.  Uterine fibroids: contrast-enhanced MR angiography to predict ovarian artery supply--initial experience. , 2006, Radiology.

[24]  H. Yoshida,et al.  Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract , 2006, The British journal of surgery.

[25]  P. Huppert,et al.  Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging. , 2006, Human reproduction.

[26]  J. Gaughan,et al.  Is Prior Uterine Surgery a Risk Factor for Adenomyosis? , 2004, Obstetrics and gynecology.

[27]  Luigi Solbiati,et al.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. , 2003, Radiology.

[28]  T. Bergholt,et al.  Prevalence and risk factors of adenomyosis at hysterectomy. , 2001, Human reproduction.

[29]  M. Tublin,et al.  Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. , 2001, AJR. American journal of roentgenology.

[30]  Lian Zhang,et al.  High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results. , 2015, Ultrasonics sonochemistry.

[31]  M. Lee,et al.  Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy. , 2011, AJR. American journal of roentgenology.